Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

A battery-free wireless implant reduces bowel inflammation in rats by electrically stimulating a nerve to the spleen over 7 ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

About Pacira Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three ...

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...

Arrowhead Clinic Chiropractor Brunswick has expanded its walk-in chiropractic services to address increasing demand for ...

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...

The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

It was only a matter of time before the concept of “longevity” made its way into our skincare routines. While the term is ...

I’ve worked at the forefront of health and wellness for a long time and I’ve seen it all, this is what’s coming in 2026 – the ...